BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28709763)

  • 21. Does Even Low-Grade Dysphonia Warrant Voice Center Referral?
    Soni RS; Ebersole B; Jamal N
    J Voice; 2017 Nov; 31(6):753-756. PubMed ID: 28396220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VHI-10 and SVHI-10 Differences in Singers' Self-perception of Dysphonia Severity.
    Renk E; Sulica L; Grossman C; Georges J; Murry T
    J Voice; 2017 May; 31(3):383.e1-383.e4. PubMed ID: 27666652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening value of V-RQOL in the evaluation of occupational voice disorders.
    Morawska J; Niebudek-Bogusz E; Wiktorowicz J; Śliwińska-Kowalska M
    Med Pr; 2018 Mar; 69(2):119-128. PubMed ID: 29300394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vocal Function Exercises for Muscle Tension Dysphonia: Auditory-Perceptual Evaluation and Self-Assessment Rating.
    Jafari N; Salehi A; Izadi F; Talebian Moghadam S; Ebadi A; Dabirmoghadam P; Faham M; Shahbazi M
    J Voice; 2017 Jul; 31(4):506.e25-506.e31. PubMed ID: 27993500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VHI-10 Scores in a Treatment-Seeking Population With Dysphonia.
    Timmons Sund L; Collum JA; Bhatt NK; Hapner ER
    J Voice; 2023 Mar; 37(2):290.e1-290.e6. PubMed ID: 33451893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Dysphonia Using the Japanese Version of the Voice Handicap Index and Determination of Cutoff Points for Screening.
    Sakaguchi Y; Kanazawa T; Okui A; Hirosaki M; Konomi U; Sotome T; Tashiro N; Kurihara M; Omae T; Nakayama Y; Yamamoto A; Sato A; Misawa K; Watanabe Y
    J Voice; 2022 Jan; 36(1):144.e1-144.e9. PubMed ID: 32591235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated With Patient-perceived Hoarseness in Spasmodic Dysphonia Patients.
    Hu A; Hillel A; Meyer T
    J Voice; 2016 Nov; 30(6):769.e23-769.e26. PubMed ID: 26704415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Time Voice Accumulation During Work, Leisure, and a Vocal Loading Task in Groups With Different Levels of Functional Voice Problems.
    Whitling S; Lyberg-Åhlander V; Rydell R
    J Voice; 2017 Mar; 31(2):246.e1-246.e10. PubMed ID: 27743846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between acoustic-perceptual data and voice-related quality of life in elderly women.
    Gama AC; Alves CF; Cerceau Jda S; Teixeira LC
    Pro Fono; 2009; 21(2):125-30. PubMed ID: 19629322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of voice therapy dropout.
    Hapner E; Portone-Maira C; Johns MM
    J Voice; 2009 May; 23(3):337-40. PubMed ID: 18674882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining voice therapy and physical therapy: A novel approach to treating muscle tension dysphonia.
    Craig J; Tomlinson C; Stevens K; Kotagal K; Fornadley J; Jacobson B; Garrett CG; Francis DO
    J Commun Disord; 2015; 58():169-78. PubMed ID: 26012419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subjective voice analysis in patients with muscular tension dysphonia: comparison between clinician and patient evaluation.
    Mateos-Serrano B; García-López I; Toledano A; Gavilán J
    J Laryngol Otol; 2021 May; 135(5):458-463. PubMed ID: 33906703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales.
    Kazi R; De Cordova J; Singh A; Venkitaraman R; Nutting CM; Clarke P; Rhys-Evans P; Harrington KJ
    J Voice; 2007 Nov; 21(6):728-34. PubMed ID: 16815670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.
    Braden MN; Johns MM; Klein AM; Delgaudio JM; Gilman M; Hapner ER
    J Voice; 2010 Mar; 24(2):242-9. PubMed ID: 19481417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voice Self-assessment Protocols: Different Trends Among Organic and Behavioral Dysphonias.
    Behlau M; Zambon F; Moreti F; Oliveira G; de Barros Couto E
    J Voice; 2017 Jan; 31(1):112.e13-112.e27. PubMed ID: 27210475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of Voice Therapy Initiation: A Cross-Sectional Cohort Study.
    Pasternak K; Diaz J; Thibeault SL
    J Voice; 2022 Mar; 36(2):194-202. PubMed ID: 32561211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphonia.
    Yeung JC; Fung K; Davis E; Rai SK; Day AM; Dzioba A; Bornbaum C; Doyle PC
    Laryngoscope; 2015 Mar; 125(3):661-6. PubMed ID: 25290557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the relationship between spectral and cepstral measures of voice and the Voice Handicap Index (VHI).
    Awan SN; Roy N; Cohen SM
    J Voice; 2014 Jul; 28(4):430-9. PubMed ID: 24698884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.